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ABSTRACT 
Pluronic nanomicelles were prepared for Ocular delivery by incorporation of methyl alcohol as a dispersing agent and the surface was 
modifying by chitosan to improve the bioavailability. Nanomicelle dispersed well in solution and having a core shell-like structure with particle 
range from 100-350 nm and zeta potential between 5.45mV -18.98mV indicating very suitable use as an ophthalmic carrier. The turbidity test 
reveals that the prepared nanomicelle were very stable under simulated tear fluid environment and simulated tear fluid, which prevent the 
blurred vision. The drug entrapment of ciprofloxacin hydrochloride in nanomicelle was too much high 98.07±6.8040. Finally, the drug release 
indicates the Pluronic nanomicelle modify by chitosan have sustained release behavior. As a result of Pluronic-Chitosan nanomicelle system 
provide a potential opportunity in decreasing dosing frequency of administration and improving patient compliance for ocular drug delivery.  
Keywords: Chitosan, Nanomicelle, Ocular delivery system, Poloxamer 407.  
 
Article Info: Received 27 Feb 2019;     Review Completed 02 April 2019;     Accepted 09 April 2019;     Available online 15 April 2019 
Cite this article as: 
Singh P, Verma N, Preparation and Characterization of Nanomicelle for Ocular delivery of fluoroquinolone derivative, 
Journal of Drug Delivery and Therapeutics. 2019; 9(2-s):355-365 http://dx.doi.org/10.22270/jddt.v9i2-s.2529          
*Address for Correspondence:  
Pawan Singh, Pharmacy Academy, IFTM University, Moradabad, U.P.- 244001, India 
 
 
INTRODUCTION 
Ocular diseases are usually treated with topical application of 
eye drops; however, this method is impeded by poor ocular 
bioavailability. 1 Mainly due to this protective characteristic 
of the ocular biological barriers. Typically, less than 5% of 
the drug applied penetrates the cornea and reaches the 
intraocular tissue. As a result, a frequent dosing regimen is 
typically necessary to achieve the therapeutic effect.  The 
topical conveyance of eye is more favored when contrasted 
with different courses of the organization as through oral for 
treatment of contamination or any illness in the eye the 
portion ought to be too high, and the impact will likewise be 
postponed. 2 While discussing eye both hydrophilic and 
hydrophobic parts demonstrate poor penetration in the eye 
and bringing about under 10% assimilation in the front 
section of the eye. Micelles consist of amphiphilic molecules 
that, generally, self-assemble in aqueous media to form 
organized supramolecular structures. Micelles are framed in 
a different size (10–1000 nm) and shapes (round, tube-
shaped, star-molded, and so on.) contingent upon the atomic 
weights of the center and crown shaping squares. 3 oneself 
get together happens after a specific fixation, alluded to as 
basic micelle focus (CMC). The power driving the self-get 
together and support of supramolecular get together is 
hydrophobic cooperation’s of center framing obstructs, for a 
run of the mill micellar structures. The crown framing square 
is water dissolvable that renders micelles solvent in the 
watery stage. Taking the benefit of the hydrophobic centre, 
the nanocarriers can be used to improve the water solvency 
of hydrophobic atoms.4 Poloxamer square copolymers have 
been abused in pharmaceutical definitions for solubilization 
of ineffectively water-dissolvable medications.5 Poloxamers 
comprise of an ethylene oxide hydrophilic centre and 
polypropylene oxide hydrophobic centre squares organized 
in a tri-square structure bringing about an amphiphilic 
structure. 6 Their capacity to self-total, accordingly framing 
micelles and fluid crystalline stages and more noteworthy 
hydrophilicity is another favorable position for the 
solubilization of dissolvable to ineffectively water-solvent 
medications. For medication conveyance purposes, 
hydrophobic medications might be solubilized within the 
center of the micelle or conjugated to the micelle-shaping a 
polymer. These amphiphilic copolymers are accessible in 
various evaluations as poloxamer 407. 7 
Chitosan is a straight polysaccharide made of arbitrarily 
appropriated β-(1-4)- connected D-glucosamine 
(deacetylated unit) and N-acetyl-D-glucosamine (acetylated 
unit). It is made by treating shrimp and other scavenger 
shells with the antacid sodium hydroxide. Chitosan has a few 
businesses and conceivable biomedical employment. 8 
Fluoroquinolones are expansive range anti-toxins (powerful 
for both Gram-negative and Gram-positive microbes) that 
assume a vital job in the treatment of genuine bacterial 
contaminations, particularly clinic obtained diseases and 
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others in which protection from more seasoned antibacterial 
classes is suspected. In light of the fact that the utilization of 
a wide range of anti-infection agents supports the spread of 
multidrug-safe strains and the advancement of Clostridium 
difficile contaminations, treatment rules. 9 Fluoroquinolones 
are regularly utilized for genitourinary diseases and are 
generally utilized in the treatment of clinic procured 
contaminations related to urinary catheters. In people group 
gained contaminations, they are suggesting just when chance 
variables for multidrug obstruction are available or after 
other anti-infection regimens have fizzled. Be that as it may, 
for genuine intense instances of pyelonephritis or bacterial 
prostatitis where the patient may be hospitalized, 
fluoroquinolones are prescribed as first-line treatment.  
 
Figure 1: Mechanism of action of Fluoroquinolones 
EXPERIMENTAL 
Materials- 
Ciprofloxacin hydrochloride (drug) was a gift sample from 
Maxchem Pharma from Rudarpur, Kolliphor®P 407 
(Poloxamer 407) was procured from Sigma Aldrich, Polyvinyl 
alcohol (PVA, 15,000 Da) and glutaraldehyde (GA) were 
procured from CDH, Span 20 and Water-soluble Chitosan 
(degree of deacetylation 75%) was procured from Sigma 
Aldrich, Sodium chloride and Calcium chloride were 
Procured from CDH, Methanol, Isopropyl alcohol, and Acetic 
acid were procured from CDH.  All other chemicals and 
reagents were of analytical grade. 
Preparation of Ciprofloxacin hydrochloride loaded 
Pluronic-Chitosan (Plu-Ch) Nanomicelles-   
Method of Preparation -  
Solvent Emulsification by Using the Triblock Copolymer- 
10 
The method is divided into two stages: 
First Stage: Preparation of Reagent Solution- 
a) Preparation of Poloxamer Solution- 
Poloxamer solution in two concentration was prepared for 
the 8 formulations. The first concentration being 14%, the 
solution was prepared by weighing 1.4gm of Poloxamer 407, 
then adding 0.5 gm followed by a gap than 0.5 gm and finally 
0.4gm after a gap to 5 ml water under magnetic stirring, then 
after a period of 10 min of stirring the remaining 5 ml was 
added into the beaker and was kept at 3-4°C for 24 hrs. to get 
a clear solution. A similar procedure for 28% solution i.e. 2.8 
gm of Poloxamer 407 was weighed accurately and was 
transferred to a beaker in three proportions as 1gm then 
with a gap 1 gm. and finally, 0.8 gm containing 5 ml of water 
under magnetic stirring. At that point in the wake of mixing 
for 10 min, the rest of the volume of 5 ml was included, and 
the container was kept at 3-4°C for 24 hrs to get a reasonable 
arrangement. 
b) Preparation of PVA Solution- 
0.25% and 0.5% solution of PVA was prepared by addition of 
0.25 and 0.5 gm of PVA into distilled water, volume made up 
to 100 ml with distilled water only and left for stirring at 70-
80 °C, till a clear solution was obtained. The solution formed 
was cooled at room temperature to be used for formulation. 
c) Preparation of Chitosan Solution 0.5%- 
Chitosan solution was prepared in Acetic acid solution 1% 
v/v. Acetic acid 1% solution was made by transferring 1 ml 
Acetic acid into a 100ml volumetric flask and then raising the 
volume to 100 ml with distilled water. Then chitosan solution 
was prepared by weighing 0.5 gm of chitosan and 
transferring it into 1% Acetic acid solution on magnetic 
stirring for 3 to 4 hours and then leaving it on overnight 
standing, to get a chitosan solution that has a little viscosity. 
 
Second Stage: Formulation stage 
Table 1: Composition of Nanomicelle   
S. No. Formulation Code Polymer Drug PVA Glutaraldehyde Chitosan Solution 
1 NM-1 28.00% 2 mg 0.25% 100μL 10 ml 
2 NM-2 14.00% 2 mg 0.25% 100μL 10 ml 
3 NM-3 28.00% 1 mg 0.25% 100μL 10 ml 
4 NM-4 14.00% 1 mg 0.50% 100μL 10 ml 
5 NM-5 28.00% 2 mg 0.50% 100μL 10 ml 
6 NM-6 14.00% 1 mg 0.25% 100μL 10 ml 
7 NM-7 14.00% 2 mg 0.50% 100μL 10 ml 
8 NM-8 28.00% 1 mg 0.50% 100μL 10 ml 
               
Preparation of Nanomicelle- 
The different formulation of nanomicelle was prepared by 
varying concentration of poloxamer, Ciprofloxacin 
hydrochloride, and PVA. The solution of drug in acetic acid 
and methanol was transferred into a solution of poloxamer 
and span 20 with continuous stirring at 2000 rpm for 2 
hours and kept aside to settle down froth. 
Separately100μL of 1 % glutaraldehyde solution in isopropyl 
alcohol and chitosan solution (10 ml) was added to the 
aqueous solution of PVA with continuous stirring for 2 
hours. 
Now, the solution of poloxamer and drug was added 
dropwise through a syringe into PVA and chitosan solution 
at 3000 rpm for 10 hours and kept aside to get a clear 
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solution without froth. This solution subject to drying at 
16°C±5°C for 12 hours. The obtained powered sample was 
cursed and stored for further evaluation. 
Evaluation Parameters – 
Drug Entrapment Efficiency- 11 
The nanomicelle is evaluated for drug entrapped, by taking a 
weighed amount of 10 mg and then dissolving that amount 
in Simulated tear fluid (STF) following magnetic stirring for 
24 hrs as in this span all the amount will be diffused from 
the nanomicelle. After 24 hrs the reading was taken by the 
help of UV visible spectrophotometer apparatus and through 
the equation, the value was noted. 
                             
                                          
                                        
     
Measurement of micelle diameter and zeta potential-12 
The micelles acquired through lyophilization were placed in 
deionized water and sonicated for 10 min to full scattering of 
micelles in deionized water. The charge of the molecule 
(known as the zeta potential) was resolved to utilize a Zeta-
sizer 3000. The electrophoretic portability of the micelles 
was estimated utilizing the laser Doppler anemometer. 
FT-IR spectra analysis of Plu-Ch Nanomicelles- 13 
The FTIR spectra of the micelles were taken, by the pellet 
technique. 5 mg sample was triturated with the 100-150 mg 
of KBr. An appropriate physical blend was made through 
trituration yet with a mellow power as unreasonable power 
may make the micelles disturb up. At that point, this blend 
was set in the depression for circle planning and was then 
exposed to pressure through the pressure machine. From 
that point onward, by utilizing the return pressure the plate 
was isolated from the circle shaping stand and was put in the 
circle holder for FTIR examination. 
Morphology observation by transmission electron 
microscopy (TEM)- 14 
The micelles got through lyophilization were placed in a 
liquor arrangement and sonicated for 10 min to full 
scattering of micelles in a liquor arrangement. The very 
much scattered micelle arrangement was then dropped onto 
400 work carbon-covered copper networks and was put on 
the broiler to expel lingering liquor through vaporization. 
The examination of the micelles was performed with a 
transmission electron magnifying lens. 
Thermal analysis of micelles-14 
By using Differential Scanning Calorimetry (DSC), 2 mg of 
drug and 2 mg of poloxamer were weighed and they were 
transferred to the two holders of the DSC apparatus one by 
one and the procedure was started by setting the temp range 
from 10 to 500 °C. The temp was increased at 5 °C per 
minute, and the aluminum was used as the reference. The 
curve was obtained and was analyzed for the study of the 
polydispersity of the drug in the polymer. 
X-Ray Diffraction (XRD) of Nanomicelle: 15 
The formulation selected from the FTIR and TEM was 
analyzed for the XRD. Minimum 1 gram of sample was taken, 
and the slide was prepared of the nanomicelle sample. The 
sample was then analyzed under XRD through a range of 
angle from 0° to 150°. This range was selected to give all the 
possible peaks of the diffraction spectra of the drug when 
the x rays are bombarded on it. The difference in the peaks 
was analyzed. If the final formulation will be in crystalline in 
nature, then the peaks will be sharper otherwise curved and 
smooth. For nanomicelle, the peaks are needed to be smooth 
as it would guarantee that the drug is fully dispersed in the 
polymer. 
Turbidity test of Nanomicelles- 16 
Various samples were placed in a quartz cuvette containing 
100 mL phosphate buffered saline (PBS) solution, setting at 
34 °C water bath. Transmittance was measured at 271 nm 
for different time periods by UV-Vis spectrophotometer and 
turbidity was calculated using the following formula: 
Turbidity = (100 - % Transmittance)/100 
In-Vitro Drug Release- 17 
The in vitro drug release study of nanomicelle was done in 
triplicate in simulated tear fluid having pH 7.2 + 0.5. The 
simulated tear fluid was freshly prepared by using the 
sodium hydrogen carbonate, sodium chloride, and calcium 
chloride. Dialysis bag of 10 cm was cut from the pile and was 
moistened in distilled water. The drug contains nanomicelle 
was loaded in dialysis bag separately, which was suspended 
in a beaker containing 50 ml simulated tear fluid under 
continuous stirring maintain at a temperature of 32± 0.5°C. 
At a definite time, interval, 1 ml aliquoted was withdrawn 
and replaced by fresh Simulated tear fluid. Withdrawn 
samples were analyzed for the drug content by UV-Visible 
spectrophotometry at a wavelength of 271 nm. 
RESULTS AND DISCUSSION 
Drug Entrapment Efficiency - 
The absorbance of the Nanomicelle solution of 10 mg was 
taken in triplicate and then kept in the equation along with 
all the multiplication factor to get the exact concentration 
that was released from the nanomicelle and then kept in the 
formula to get the entrapment as shown in the table below, 
 
Table 2: % Drug Entrapment Efficiency of Nanomicelle 
S.No. Formulation code % Drug entrapment 
1 NM-1 84.91±3.4029 
2 NM-2 82.76±3.3950 
3 NM-3 86.97±3.1250 
4 NM-4 92.93±6.3827 
5 NM-5 98.58±6.8040 
6 NM-6 71.55±12.3677 
7 NM-7 89.06±3.4112 
8 NM-8 90.12±6.4446 
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The formulation NM-5 showing highest drug entrapment 
98.58%±6.8040 and the chitosan used do not interfere in the 
release from the formulation. The modification in the 
entrapment was basically due to the different concentration 
of PVA and Poloxamer 407 used, even the amount loaded 
caused a huge variation in the entrapment. So, on this basis, 
four formulations were selected for further study. 
Measurement of micelle diameter and zeta potential 
The particle size and polydispersity index were studied, for 
the formulation of NM- 5 based on high drug entrapment. 
The size obtained through this measurement was found to be 
a little larger than reported only with the Poloxamer, as the 
chitosan polymer forms a positive charge layer over it, that 
increases the size. This layer formed is very useful as it first 
erodes to release the drug followed by the further release, 
but this increases the particle size.  This layering is of 
importance as it helps in binding with the inner core of the 
eye and increases the nanomicelle residence time in the eye 
and make it feasible for the delayed and prolonged action 
accompanied with no scarcity of the drug during the 
treatment. If this layer is not formed than the particles may 
release the drug in a more prolonged time than the usual and 
maybe there is a scene of scarcity in the eye for the 
treatment of infection. Thus, this layering is important. 
  
 
 
Figure 2: Distribution graph of particle size formulation obtained from zeta sizer. 
 
Figure 3: Distribution graph of zeta potential formulation obtained from zeta sizer. 
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FT-IR spectra analysis of Plu-Ch Nanomicelles- 
 
Figure 4: A Chromatogram of FTIR for Ciprofloxacin hydrochloride 
 
Table 4: Interpretation of pure Ciprofloxacin hydrochloride  
Characteristic peaks  Peaks (cm-1) 
Hydroxyl group 3526.99 
Aromatic cyclic enes 2923.25 
CO group of acid 1706.11 
Quinolones 1620.27 
Carbonyl 1449.51 
Hydroxyl (δ O-H bending) 1323.22 
Fluorine (C-F stretching) 1031.00 
 
 
Figure 5: A Chromatogram of FTIR for Poloxamer 407 
 
Table 5: Interpretation of poloxamer 407 
S.No. Characteristic peaks Peaks(cm-1) 
1. C-H stretch aliphatic 2893.02  
2. plane O-H bend 1355.86  
3. C-O stretch 1124.42  
4. CH=CR2 841  
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Figure 6: A Chromatogram of FTIR for Nanomicelle 
 
Table 6- Interpretation of drug loaded Nanomicelle   
S.N. Characteristic peaks Peaks (cm-1) 
1 Hydroxyl group 3448.41 
2 Aromatic cyclic enes 2881.71 
3 CO group of acid 1712.76 
4 Quinolones 1643.42 
5 Carbonyl 1465.00 
6 Hydroxyl (δ O-H bending) 1356.98 
7 Fluorine (C-F stretching) 1106.22 
8 C-H stretch aliphatic (polymer) 2879.85 cm–1 
9 O-H bend (polymer) 1356.86 cm–1 
10 C-O stretch (polymer) 1160.42 cm–1 
11 CH=CR2 (polymer) 842.93 cm–1 
 
The peaks increment showed that the drug was completely 
in the formulation, no more peaks for alcohol or less 
importance in the -OH peak showed us that the alcohol that 
was used for the formulation as the dispersing agent has 
been evaporated and that is not present in the formulation. 
Peaks showed were almost equivalent to that of the drug, 
proving that the drug is nicely dispersed in the polymer.  
Morphology observation by transmission electron 
(TEM)- 
The TEM analysis of the formulation was done, and the result 
is as shown in figure 7-9. The particle size was obtained 101 
to 131 nm and 98.6 to 99.8 nm for NM-5, as shown in the 
figures. The results were taken at 40,000 magnification and 
in a range of 500nm. The cloudy less dense area shows the 
nanomicelle and the dark spotted area shows the drug. In 
almost every nanomicelle the drug was entrapped in the 
micelle, and the nanomicelle obtained is an almost oval or 
round shape. The nanomicelle thus formed is clear, now the 
point is of the surface modification. The surface modified 
nanomicelle must be bigger in size and lie in the range of 
100-131nm. This is because the surface was modified by the 
chitosan layer, that helped in providing a positive charge to 
the sphere. This charge is created when the arrangement is 
framed and will empower the medication in official in the 
eye or in the layers through electrostatic connection, as the 
eye climate or the layers convey a negative charge, this 
charge is the principal reason for the nanomicelle through 
chitosan plan. According to the writing, the polymeric 
nanomicelle just from Poloxamer will be inside 100 nm, and 
the nanomicelle after the chitosan layer will have a size 
greater than the nanomicelle with just the polymer 
 
 
Figure 7: Transmission Electron microscopy of drug loading Nanomicelle  
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Figure 8: Transmission Electron microscopy of drug loading Nanomicelle with a particle size 
 
 
Figure 9: Transmission Electron microscopy of drug loading Nanomicelle with a particle size 
Thermal analysis of micelles- 
The thermal analysis was carried out the results are as 
shown in figure 10, and that of the drug at dehydration peak 
148.72 °C and the melting point was found to be 323.43°C.  
The peaks were evaluated, for the proper melting point and 
were found to be correct. A peak at 117.60 °C in the drug 
DSC curve showed the presence of moisture. 
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Figure 10: A Representative Chromatogram of DSC for Ciprofloxacin hydrochloride 
The DSC of the Poloxamer 407 showed a single peak at the 
56.18 °C and in this study the poloxamer 407 is showing the 
sharp endotherm that means the poloxamer 407 is highly 
pure and the high temperature showing the degradation of 
poloxamer 407 but at the high temperature no endotherm is 
shown so it represents that’s no other material present in the 
polymer.
 
 
Figure 11: A Representative Chromatogram of DSC for Poloxamer 407 
 
Figure 12: A representative Chromatogram of DSC for Nanomicelle 
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In figure 12, the endotherm of poloxamer 407 is sharp but 
the melting point is shift 1°C that’s mean the drug is 
completely entrapped in the polymer and the drug peak has 
shifted to a long way. The high shift is the reason because the 
drug is in very less amount as compared to the polymer, even 
the literature showed that in case of Poloxamer high 
concentration the shift is always very less and here the 
percentage is 0.01, meaning a quite low one so a little shift 
only. In the curve, we only see a little bulge around 323.43 °C, 
not a peak. This means that the drug is highly dispersed in 
the polymer and the formulation is a success. So, we can say 
that the drug is easily carried by the polymer. 
X-Ray Diffraction (XRD) of Nanomicelle:  
The nanomicelle so formed was analyzed through powder X-
Ray diffractometer. The powder diffraction of the drug was 
compared with that of the dried nanomicelle. In the spectra 
of the drug the peaks were quite pointed and sharp, showing 
the drug is sole present in it. But when the combination was 
analyzed in the apparatus, the sharp peaks changed to 
curved. This proved that the drug properly went into the 
polymer. 
 
 
 
Figure 13: A Chromatogram of X-Ray Diffraction for Ciprofloxacin hydrochloride 
 
 
Figure 14: A Chromatogram Diffraction of X-Ray for Nanomicelle 
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Turbidity test of micelles-  
During the time spent ophthalmic medication conveyance 
utilizing nanomicelle, suspension with outrageous fixation 
may cause obscure in eyes. To keep from the disability of 
vision without bringing down the grouping of medications 
during the time spent the treatment, turbidity explore was 
directed in a domain reenacting the eyes. When absorbing 
micelles Simulated tear fluid arrangement, turbidity, which 
expands molecule distance across as well as turbidity; 
besides, it is discovered that turbidity demonstrates an 
upward pattern with time, which is credited to the 
extraordinary union in nanoscale protests as Nanoparticles 
in the suspension arrangement will, in general, accumulate 
after some time. Such assembling builds molecule distance 
across and brings down the light entrance, prompting 
expanding turbidity.  
The turbidity of the considerable number of tests increments 
with expanding splashing time; yet their turbidities are for 
the most part under 0.2 subsequent to absorbing Simulated 
tear fluid for 0-hour, 6 hour and 12 hours. shows that light 
transmission ≥ 90% (i.e., turbidity ≤ 0.1) is characterized as 
straightforward, 10–90% is translucent, and one lower than 
10% is obscure. 80% of straightforwardness (turbidity = 0.2) 
is as far as possible for vision turbidity which does not make 
a foggy vision. It is discovered that suspensions of 
nanomicelle arranged in this investigation to keep up their 
unique lucidity when controlled to the eyes, their 
straightforwardness manufactures in the suitable range, 
which makes them a potential application in the ophthalmic 
medication. 
 
Table 7: Turbidity analysis of Nanomicelle 
TURBIDITY ANALYSIS 
S.NO. 
AVG. % 
Turbidity 
AVG. % 
Turbidity 
AVG. % 
Turbidity 
Trans. Trans Trans. 
  (ZERO HR)   (6 HR)   (12 HR)   
NM-1 95.7 0.031 92.5 0.061 90.2 0.084 
NM-2 98.4 0.021 95.7 0.049 90.7 0.098 
NM-3 96.6 0.041 91.6 0.087 89.1 0.099 
NM-4 96.7 0.033 93.5 0.065 91.2 0.088 
NM-5 98.2 0.018 95.4 0.046 90.4 0.096 
NM-6 97.3 0.029 92.7 0.078 90.8 0.098 
NM-7 96.1 0.039 91.2 0.088 89.8 0.102 
NM-8 97.4 0.026 92.5 0.075 90.5 0.095 
 
In-Vitro Drug Release-  
The Nanomicelle solution of 10 mg Nanomicelle in Simulated 
tear fluid was analyzed through the absorbance recording 
corresponding to each sample withdrawn at the predefined 
intervals was taken by the help of UV-Vis Spectrophotometer. 
These absorbances were noted after sufficient dilution to get 
a value in the Beer-Lambert range. The release of the drug 
was calculated, and the pattern of release was studied where 
it was found that it showed a slow initial release till 30 min to 
840 min. All formulations were showing initially burst 
release and then a sustained release to achieved 100% drug 
released. 
 
 
Figure 15: In vitro evaluation of Nanomicelles 
The Vitro tests for Nanomicelles were studied and the final 
results were produced in figure 15 rapid release of 
polymeric nanomicelle during the initial stages was 
observed in Nano formulations. This could be due to the 
desorption and diffusion of poloxamer from the outer 
surface of micelles. It is always preferred initial burst from 
the controlled drug delivery systems to attain a threshold 
dose for proper elicitation of therapeutic action. After the 
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initial rapid release, poloxamer micelles showed a constant 
slow and sustained release and the maximum drug was 
released in, whereas the drug formulation showed the initial 
constant slow release. 
All formulation was shown the maximum amount of drug 
release within of its administration. The slow release pattern 
of micelles after initial rapid release had been reported 
earlier and our system was consistent with the literature 
and showed slow diffusion from micelles. Also showed a 
slow and sustained release with the maximum drug release 
at hrs. To maintain safer therapeutic concentrations of a 
drug for a stipulated time, always a slow and sustained drug 
release formulation is desirable to avoid any toxic systemic 
effects. Hence, we suggest that the poloxamer micelles offer 
an effective controlled drug delivery system with reduced 
systemic side effects and enhanced targeting efficiency. 
CONCLUSION 
In this study, Pluronic chitosan-based nanomicelle were 
successfully preparade ophthalmic delivery by incorporation 
of methyl alcohol as a dispersing agent and chitosan worked 
as a surface modifier which helps to their bioavailability. The 
physicochemical characterization of Pluronic-Chitosan 
nanomicelle including diameter, surface charge, 
morphology, turbidity, loading efficiency and drug 
entrapment that they are exceptionally appropriate to use as 
an ophthalmic bearer. In vitro, micelles have supported 
discharge conduct and better therapeutic reaction. The 
framework gives enhancing understanding consistency to 
visual medication conveyance. 
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